Skip to content
healthcare.dev

Ezetimibe and Simvastatin

NDC 59651-837, Ezetimibe and Simvastatin, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-837
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200082
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-837 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EZETIMIBE10 mg/1
  • SIMVASTATIN40 mg/1

Pharmacologic classes

Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]; HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
59651-837-305965108373030 TABLET in 1 BOTTLE (59651-837-30)
59651-837-905965108379090 TABLET in 1 BOTTLE (59651-837-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/79dadfde-35c7-4937-9c82-1728fb6be2fb

Use it

Look up 59651-837 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-837 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-837. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.